Risk of Radiation -Associated Secondary Malignancies among Patients with Breast Cancer Harboring TP53 Germline Variants

被引:0
|
作者
Cederquist, G. [1 ]
Boe, L. [2 ]
Walsh, M. F. [3 ]
Stadler, Z. [4 ]
Xu, A. J. [5 ]
Mueller, B. A. [5 ]
O'Brien, D. A. Roth [5 ]
Bernstein, M. B. [5 ]
Cuaron, J. [5 ]
Bakhoum, S. F. [3 ]
Powell, S. N. [5 ]
Khan, A. J. [5 ]
Robson, M. E. [4 ]
Maxwell, K. [6 ]
Taunk, N. K. [7 ]
Braunstein, L. Z. [5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Radiat Oncol, New York, NY USA
[2] Mem Sloan Kettering, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA
[6] Univ Penn, Philadelphia, PA USA
[7] Univ Penn, Hosp, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
181
引用
收藏
页码:S45 / S46
页数:2
相关论文
共 50 条
  • [1] Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring TP53 Germline Variants
    Cederquist, Gustav Y.
    Boe, Lillian A.
    Walsh, Michael
    Freedman, Gary M.
    Maxwell, Kara N.
    Taunk, Neil
    Braunstein, Lior Z.
    JAMA ONCOLOGY, 2024,
  • [2] Germline TP53 pathogenic variants and breast cancer: A narrative review
    Blondeaux, Eva
    Arecco, Luca
    Punie, Kevin
    Graffeo, Rossella
    Toss, Angela
    De Angelis, Carmine
    Trevisan, Lucia
    Buzzatti, Giulia
    Linn, Sabine C.
    Dubsky, Peter
    Cruellas, Mara
    Partridge, Ann H.
    Balman, Judith
    Paluch-Shimon, Shani
    Lambertini, Matteo
    CANCER TREATMENT REVIEWS, 2023, 114
  • [3] Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li–Fraumeni syndrome)
    Vanessa Petry
    Renata Colombo Bonadio
    Allyne Queiroz Carneiro Cagnacci
    Luiz Antonio Leite Senna
    Roberta do Nascimento Galvão Campos
    Guilherme Cutait Cotti
    Paulo M. Hoff
    Maria Candida Barisson Villares Fragoso
    Maria del Pilar Estevez-Diz
    Familial Cancer, 2020, 19 : 47 - 53
  • [4] Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome)
    Petry, Vanessa
    Bonadio, Renata Colombo
    Carneiro Cagnacci, Allyne Queiroz
    Leite Senna, Luiz Antonio
    Galvao Campos, Roberta da Nascimento
    Cotti, Guilherme Cutait
    Hoff, Paulo M.
    Barisson Villares Fragoso, Maria Candida
    Estevez-Diz, Maria del Pilar
    FAMILIAL CANCER, 2020, 19 (01) : 47 - 53
  • [5] Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
    Emilia Rogoża-Janiszewska
    Karolina Malińska
    Bohdan Górski
    Rodney J. Scott
    Cezary Cybulski
    Wojciech Kluźniak
    Marcin Lener
    Anna Jakubowska
    Jacek Gronwald
    Tomasz Huzarski
    Jan Lubiński
    Tadeusz Dębniak
    Breast Cancer, 2021, 28 (1) : 226 - 235
  • [6] Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
    Rogoza-Janiszewska, Emilia
    Malinska, Karolina
    Gorski, Bohdan
    Scott, Rodney J.
    Cybulski, Cezary
    Kluzniak, Wojciech
    Lener, Marcin
    Jakubowska, Anna
    Gronwald, Jacek
    Huzarski, Tomasz
    Lubinski, Jan
    Debniak, Tadeusz
    BREAST CANCER, 2021, 28 (01) : 226 - 235
  • [7] Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families
    Xuan Liu
    Hans-Peter Sinn
    Hans Ulrich Ulmer
    Rodney J Scott
    Ute Hamann
    Hereditary Cancer in Clinical Practice, 2 (3)
  • [8] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [9] Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study)
    Packwood, Kate
    Martland, Guy
    Sommerlad, Matthew
    Shaw, Emily
    Moutasim, Karwan
    Thomas, Gareth
    Bateman, Adrian C.
    Jones, Louise
    Haywood, Linda
    Evans, D. Gareth
    Birch, Jillian M.
    Alsalmi, Ohud A.
    Henderson, Alex
    Poplawski, Nicola
    Eccles, Diana M.
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2019, 5 (03): : 189 - 198
  • [10] Phenotype and prognosis of patients with breast cancer and pathogenic TP53 variants
    Petry, Vanessa
    CANCER RESEARCH, 2021, 81 (04)